We investigated the incidence of extracapsular spread (ECS) and the impact of ECS on contralateral neck metastasis in 67 patients with ipsilateral nodal metastasis (IpN+) whose records were extracted retrospectively from those of 155 laryngeal cancer patients. The incidence of ECS in association with variables was determined: T stage, N stage, tumor location, tumor extension, number of positive nodes, and contralateral neck status. The variables were evaluated to identify their impact on the rates of contralateral neck metastasis (CNM) and 3-year survival. Of the 67 patients, 30 (44.7%) had ECS. A significant relationship was found between ECS positivity and increased N stage, tumor extension up to the midline, number of positive nodes, and CNM (p = .04, p = .0001, p = .018, p = .0001, respectively). Multivariate analysis revealed that N stage (p = .002; odds ratio, 3.5517) and the presence of ECS (p = .0036; odds ratio, 7.7840) in IpN+ were associated with the greatest risk of CNM. The 3-year survival rate of patients with ipsilateral ECS was significantly lower than that of patients without ECS (43% versus 81%, p = .0002). Both CNM and presence of ECS in IpN+ emerged as significant independent predictors for survival with Cox multivariate analysis (p = .0086 and p = .0234, respectively). This result indicates the necessity of treating the contralateral NO neck in cases of IpN+ with ECS.
ByersRMWolfPFBallantyneAJ. Rationale for elective modified neck dissection. Head Neck Surg1988; 10: 160–7.
2.
CarterRLBlissJMSooKCO'BrienCJ. Radical neck dissections for squamous carcinomas: Pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys1987; 13: 825–32.
3.
CarterRL. The pathologist's appraisal of neck dissections. Eur Arch Otorhinolaryngol1993; 250: 429–31.
4.
HirabayashiHKoshiiKUnoK. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: Prognostic factor of laryngeal cancer. Laryngoscope1991; 101: 502–6.
5.
JohnsonJTMyersENBedettiCDBarnesELSchrammVLJrThearlePB. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol1985; 111: 534–7.
6.
JohnsonJTBarnesLMyersENSchrammVLJrBorochovitzDSiglerBA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol1981; 107: 725–9.
7.
GilliesEMLunaMA. Histologic evaluation of neck dissection specimens. Otolaryngol Clin North Am1998; 31: 759–71.
8.
AlviAJohnsonJT. Extracapsular spread in the clinically negative neck (NO): Implications and outcome. Otolaryngol Head Neck Surg1996; 114: 65–70.
9.
BarzanLTalaminiR. Analysis of prognostic factors for recurrence after neck dissection. Arch Otolaryngol Head Neck Surg1996; 122: 1299–302.
10.
LeemansCRTiwariRNautaJJPvan der WaalISnowGB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer1993; 71: 452–6.
HaoSMyersENJohnsonJT. T3 glottic carcinoma revisited. Transglottic vs pure glottic carcinoma. Arch Otolaryngol Head Neck Surg1995; 121: 166–70.
13.
OlsenKDCarusoMFooteRL. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg1994; 120: 1370–4.
14.
NicolaiPde ZinisRedaelli LOTomenzoliD. Prognostic determinants in supraglottic carcinoma: Univariate and Cox regression analysis. Head Neck1997; 19: 323–34.
15.
PinsolleJPinsolleVMajoufreCDurouxSDemeauxHSiberchicotF. Prognostic value of histologic findings in neck dissections for squamous cell carcinoma. Arch Otolaryngol Head Neck Surg1997; 123: 145–8.
16.
MamelleGPampurikJLuboinskiBLancarRLusinchiABosqJ. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg1994; 168: 494–8.
FisherLDvan BelleG. Biostatistics. A methodology for the health sciences. New York, NY: John Wiley & Sons, 1993.
19.
Morales-AnguloCVal-BernalFBueltaLFernandezFGarcia-CastrilloLRamaJ. Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg1998; 119: 548–53.
20.
CerezoLMillanITorreAAragonGOteroJ. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer1992; 69: 1224–34.
21.
de GuzmanBarona RMartorellMABasterraJArmengotMAlvarez-ValdesRGarinL. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas. Laryngoscope1993; 103: 538–40.
22.
LiXMWeiWIGuoXFYuenPWLamLK. Cervical lymph node metastatic patterns of squamous carcinomas in the upper aerodigestive tract. J Laryngol Otol1996; 110: 937–41.
23.
ShahJP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg1990; 160: 405–9.
24.
TruelsonJMFisherSGBealsTEMcClatcheyKDWolfGT. DNA content and histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. Cancer1992; 70: 56–62.
25.
SnydermanNLJohnsonJTSchrammVLJrMyersENBedettiCDThearleP. Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx. Cancer1985; 56: 1597–9.
26.
KalninsIKLeonardAGSakoKRazackMSSheddDP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg1977; 134: 450–4.
27.
SteinhartHSchroederHGBuchtaBSchmidtAKleinsasserO. Prognostic significance of extra-capsular invasion in cervical lymph node metastases of squamous epithelial carcinoma [in German]. Laryngorhinootologie1994; 73: 620–5.
28.
RichardJMSancho-GarnierHMicheauCSaravaneDCachinY. Prognostic factors in cervical lymph node metastasis in upper respiratory and digestive tract carcinomas: Study of 1,713 cases during a 15-year period. Laryngoscope1987; 97: 97–101.
29.
SchullerDEBier-LaningCM. Laryngeal carcinoma nodal metastases and their management. Otolaryngol Clin North Am1997; 30: 167–77.
30.
MarksJEDevineniVRHarveyJSessionsDG. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol1992; 13: 34–9.
31.
MillionRRCassisiN. Management of head and neck cancer: a multidisciplinary approach. Philadelphia, Pa: JB Lippincott, 1984.
32.
SessionsRBHudkinsCP. Malignant cervical adenopathy. In: CummingsCWFredricksonJMHarkerLAKrauseCJSchullerDE, eds. Otolaryngology—head and neck surgery. Vol 2. St Louis, Mo: Mosby, 1993: 1605–25.
33.
LevendagPSessionsRVikramB. The problem of neck relapse in early stage supraglottic larynx cancer. Cancer1989; 63: 345–8.
34.
GalloOFini-StorchiINapolitanoL. Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1–3). Head Neck2000; 22: 386–92.
35.
LutzCKJohnsonJTWagnerRLMyersEN. Supraglottic carcinoma: Patterns of recurrence. Ann Otol Rhinol Laryngol1990; 99: 12–7.
36.
PitmanKTJohnsonJTMyersEN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg1997; 123: 917–22.
37.
MyersENAlviA. Management of carcinoma of the supraglottic larynx: Evolution, current concepts, and future trends. Laryngoscope1996; 106: 559–67.
38.
KowalskiLPFrancoELde Andrade SobrinhoJ. Factors influencing regional lymph node metastasis from laryngeal carcinoma. Ann Otol Rhinol Laryngol1995; 104: 442–7.
39.
MoeKWolfGTFisherSGHongWK. Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg1996; 122: 644–8.
40.
LefebvreJLCastelainBDe la TorreJCDelobelle-DeroideAVankemmelB. Lymph node invasion in hypopharynx and lateral epilarynx carcinoma: A prognostic factor. Head Neck Surg1987; 10: 14–8.
41.
JohnsonJTWagnerRLMyersEN. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck. Cancer1996; 77: 181–5.
